Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized salbutamol dose comparison in preterm infants developing bronchopulmonary dysplasia
NL-OMON33377Phase 4Recruiting
- Sponsor
- Isala
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of salbutamol in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Isala. Primary endpoint: Fall in serum potassium. Started Apr 2009; status: recruiting.
02
Drugs
salbutamol
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NL-OMON33377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33377.